Supporting Biotech on their Commercialisation Pathway to Maximise Value from Early Clinical Development to Launch.
With Genchrome's team of experienced pharmaceutical experts, we provide commercial & access support to biotech all along the lifecycle from preclinical, phase I,II,II to launch. 🧬
Our Vision - Throughout our experience, we noticed 3 main trends:
1. Nearly half of biotech launches underperformed.
2. Launch Pioneers, despite high level of innovation are overall less successful than established market innovatorsÂ
3. New biotech launching themselves generally achieve lower sales than in partnership with pharma
With our team of international experts with strong pharmaceutical expertise, we want to help you avoid making these mistakes.
What We Do:
- New Product Launch
- Launch Planning
- Portfolio Planning
- BD and M&A
- Payers
- Pharma Partnerships
Our Fields Of Expertise From Pre-launch To Launch:
- Orphan
- Neurology
- Hemato-Oncology
- Oncology
- Biosimilars
- Hematology
- Infectiology
- Immunology & Inflammation
- Cardiovascular
- Nephrology
- Ophtalmology
For more information, please contact us at: contact@genchrome.com
Company Details
- Employees
- 5
- Founded
- 2022
- Address
- London, Gb
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- https://genchrome.com/
- Keywords
- Immunology, Neurology, Infectious Diseases, Haemato & Oncology, Covid-19, NASH, Biosimilars, Rare diseases, Biotech, Drug launch.
- HQ
- London
Genchrome Questions
Genchrome's website is https://genchrome.com/
Genchrome's LinkedIn profile is https://uk.linkedin.com/company/genchromeltd
Genchrome has
5 employees.
View email and phone details for 5
employees at Genchrome.
Genchrome's industry is
Business Consulting and Services
Genchrome's categories are Business Consulting and Services
Genchrome's founding year is 2022
